We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Bespak Launches Syrina AR 2.25 Auto-Injector
Product News

Bespak Launches Syrina AR 2.25 Auto-Injector

Bespak Launches Syrina AR 2.25 Auto-Injector
Product News

Bespak Launches Syrina AR 2.25 Auto-Injector


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Bespak Launches Syrina AR 2.25 Auto-Injector"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Bespak has announced the launch of the Syrina™ AR 2.25 auto-injector. This innovative auto-injector is the latest addition to the VapourSoft™ -powered Syrina range and is suitable for delivering volumes of up to 2ml using a standard 2.25ml pre-filled syringe. The Syrina AR 2.25 provides patients with a fully-automatic two-step, compact device for the self-administration of viscous drug formulations.

Using Bespak’s proven proprietary compact energy source, VapourSoft, Syrina AR 2.25 is able to deliver 2 ml of viscous drug solutions smoothly and safely in less than 15 seconds. Designed with a hidden needle, Syrina AR 2.25 offers automatic needle insertion and retraction, as well as drug delivery with a single push-on-skin operation.

Syrina AR 2.25 has been tailored specifically for higher viscosities while still enabling the safe use of glass syringes. Using VapourSoft at its core allows a compact design and, with quiet operation, provides a discrete solution for patients. Syrina AR 2.25 is clinical trial ready, enabling a fast track implementation process once paired with a specific drug formulation.

Keyvan Djamarani, Managing Director, Bespak commented: “There is increasing demand from the industry for innovative drug delivery devices that enable self-administration of the latest challenging drug formulations. As viscosities and dosage volumes both increase, the ability to safely and quickly deliver the dose remain paramount. For the first time, Syrina AR 2.25 incorporates our revolutionary compact energy source, VapourSoft, into a fully-automatic compact auto-injector device, designed specifically to meet the industry’s most demanding needs.” Other injection devices in Bespak’s Syrina range include the Syrina Micro, Syrina Mini, Syrina S and Syrina AS.

Advertisement